These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22508654)

  • 21. A quick one-tube nested PCR-protocol for EPO transgene detection.
    Moser DA; Neuberger EW; Simon P
    Drug Test Anal; 2012 Nov; 4(11):870-5. PubMed ID: 22539489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene doping: an overview and current implications for athletes.
    van der Gronde T; de Hon O; Haisma HJ; Pieters T
    Br J Sports Med; 2013 Jul; 47(11):670-8. PubMed ID: 23322893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current limitations and future perspectives of the Athlete Blood Passport.
    Lippi G; Plebani M; Sanchis-Gomar F; Banfi G
    Eur J Appl Physiol; 2012 Oct; 112(10):3693-4. PubMed ID: 22441832
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
    Schumacher YO; Saugy M; Pottgiesser T; Robinson N
    Drug Test Anal; 2012 Nov; 4(11):846-53. PubMed ID: 22374784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current markers of the Athlete Blood Passport do not flag microdose EPO doping.
    Ashenden M; Gough CE; Garnham A; Gore CJ; Sharpe K
    Eur J Appl Physiol; 2011 Sep; 111(9):2307-14. PubMed ID: 21336951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OMICS-strategies and methods in the fight against doping.
    Reichel C
    Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proof of Gene Doping in a Mouse Model with a Human Erythropoietin Gene Transferred Using an Adenoviral Vector.
    Sugasawa T; Nakano T; Fujita SI; Matsumoto Y; Ishihara G; Aoki K; Yanazawa K; Ono S; Tamai S; Manevich L; Ueda H; Ishibashi N; Tamai K; Kanki Y; Yoshida Y; Watanabe K; Takemasa T; Kawakami Y; Takekoshi K
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent progress of doping tests in sports].
    Ueki M
    Chudoku Kenkyu; 2003 Jul; 16(3):307-13. PubMed ID: 14582353
    [No Abstract]   [Full Text] [Related]  

  • 29. Blood doping: risks to athletes' health and strategies for detection.
    Oliveira CD; Bairros AV; Yonamine M
    Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A duplex qPCR assay for human erythropoietin (EPO) transgene to control gene doping in horses.
    Cheung HW; Wong KS; Lin VYC; Wan TSM; Ho ENM
    Drug Test Anal; 2021 Jan; 13(1):113-121. PubMed ID: 32762114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EPO transgene detection in dried blood spots for antidoping application.
    Marchand A; Roulland I; Semence F; Ericsson M
    Drug Test Anal; 2021 Nov; 13(11-12):1888-1896. PubMed ID: 33961347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting doping use: more than an analytical problem.
    Delanghe JR; Maenhout TM; Speeckaert MM; De Buyzere ML
    Acta Clin Belg; 2014; 69(1):25-9. PubMed ID: 24635395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin and blood doping.
    Robinson N; Giraud S; Saudan C; Baume N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i30-4. PubMed ID: 16799100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood doping : infusions, erythropoietin and artificial blood.
    Eichner ER
    Sports Med; 2007; 37(4-5):389-91. PubMed ID: 17465616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening and confirmatory analysis of recombinant human erythropoietin for racing camels' doping control.
    Delcourt V; Garcia P; Chabot B; Loup B; Remy P; Popot MA; Bailly-Chouriberry L
    Drug Test Anal; 2020 Jun; 12(6):763-770. PubMed ID: 31984676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oxygen blood transport and doping].
    Audran M; Connes P; Varlet-Marie E
    Bull Acad Natl Med; 2003; 187(9):1669-79; discussion 1680-3. PubMed ID: 15369237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene doping.
    Haisma HJ; de Hon O
    Int J Sports Med; 2006 Apr; 27(4):257-66. PubMed ID: 16572366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New type of redox nanoprobe: C60-based nanomaterial and its application in electrochemical immunoassay for doping detection.
    Han J; Zhuo Y; Chai YQ; Xiang Y; Yuan R
    Anal Chem; 2015 Feb; 87(3):1669-75. PubMed ID: 25547661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection methods for autologous blood doping.
    Segura J; Monfort N; Ventura R
    Drug Test Anal; 2012 Nov; 4(11):876-81. PubMed ID: 22407819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
    Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
    Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.